US Broker Ratings

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 42.79% Potential Upside in the Medical Instruments Sector

Stevanato Group S.p.A. (NYSE: STVN), a key player in the Healthcare sector, offers a compelling investment opportunity as it navigates the dynamic landscape of the Medical Instruments & Supplies industry...

Tenet Healthcare Corporation (THC) Stock Analysis: Why a 39% Potential Upside is Captivating Investors

Tenet Healthcare Corporation (NYSE: THC) stands at a pivotal moment in the healthcare sector, presenting a compelling investment opportunity with a substantial potential upside of 39.48%. As the company navigates..

Danaher Corporation (DHR) Investor Outlook: Analyzing a Potential 34.56% Upside in the Diagnostics & Research Sector

Danaher Corporation (NYSE: DHR) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Washington, D.C., this $127.47 billion behemoth has been..

Masimo Corporation (MASI) Stock Analysis: Evaluating the Healthcare Innovator’s Performance and Prospects

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its innovative approach to patient monitoring technologies. Headquartered..

Stryker Corporation (SYK): Potential 23.89% Upside Amid Robust Buy Ratings and Strategic Growth

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, has been drawing significant attention from investors, thanks to its promising growth potential and strong market positioning in the..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 80% Upside Potential in Healthcare Technology

Waystar Holding Corp. (WAY), a dynamic player in the healthcare technology sector, is attracting significant attention from investors, with a noteworthy potential upside of 80.41% according to analyst ratings. As..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking the 42% Potential Upside and Strategic Healthcare Position

Investors eyeing opportunities in the healthcare sector may find Grifols, S.A. (GRFS) an intriguing prospect. With a market capitalization of $5.2 billion and a diverse portfolio in plasma-derived medicines, Grifols..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 46.80% Potential Upside in the Biotech Arena

For individual investors seeking a defensive yet promising sector, the healthcare industry offers a wealth of opportunities, and Genmab A/S (GMAB) stands out as a noteworthy contender. Headquartered in Copenhagen,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A Look at Potential Upside and Analyst Ratings

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specifically in the medical devices industry, offers a unique investment opportunity amidst a challenging market environment. With a..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a 21.72% Upside Potential in the Biotech Sector

Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage precision oncology company, is making waves in the biotechnology industry with its cutting-edge approach to combating RAS-addicted cancers. Operating out of Redwood City,..

Qiagen N.V. (QGEN) Stock Analysis: Exploring an 18% Upside Potential for Investors

Qiagen N.V. (QGEN), a key player in the healthcare sector, particularly in diagnostics and research, has caught the attention of investors with its promising potential upside. Based in the Netherlands..

Amgen Inc. (AMGN) Stock Report: Valuation Insights Amid Robust Dividend Yield and Revenue Growth

Amgen Inc. (NASDAQ: AMGN) stands out in the healthcare sector, particularly in the general drug manufacturing industry, with a significant market capitalization of $191.7 billion. As a major player in..

Revvity, Inc. (RVTY) Stock Analysis: Tracking a 14% Upside Potential in the Healthcare Diagnostics Sector

Revvity, Inc. (NYSE: RVTY), formerly known as PerkinElmer, Inc., stands as a prominent player in the healthcare diagnostics and research sector. This Massachusetts-based company, with a market capitalization of $11.12..

Humana Inc. (HUM) Stock Analysis: Navigating the Healthcare Plans Sector with a 23.5% Revenue Growth

Humana Inc. (NYSE: HUM) stands as a significant player in the healthcare plans industry, commanding a market capitalization of $45.53 billion. Situated within the broader healthcare sector, Humana is a..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a Potential Upside

Baxter International Inc. (BAX), a prominent player in the healthcare sector, offers a diverse range of medical instruments and supplies. Headquartered in Deerfield, Illinois, the company holds a market capitalization..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Evaluating a Potential 103.85% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT), a significant player in the biotechnology sector, has drawn considerable attention from investors due to its promising potential upside of 103.85%. With a market capitalization..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a 4.98% Potential Upside in the Healthcare Giant

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor attention with its strong market presence and promising growth metrics. With a market capitalization of..

West Pharmaceutical Services (WST) Investor Outlook: Promising Upside with Strong Buy Ratings

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a beacon of innovation in the healthcare sector, specializing in the design and production of containment and delivery systems for injectable drugs...

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 26.43% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands out as a powerhouse in the healthcare sector, particularly within the diagnostics and research industry. With a robust market capitalization of $44.24 billion, IDEXX..

Chemed Corp (CHE) Stock Analysis: Evaluating Growth Potential Amid Market Fluctuations

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, primarily operates within the medical care facilities industry. Based in the United States, Chemed delivers hospice and palliative care..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds